Potentiation of Halogenated Pyrimidine Radiosensitizers in Human Carcinoma Cells by β-Lapachone (3,4-dihydro-2,2-dimethyl-2h-naphtho[l,2-b]pyran-5,6-dione), a Novel DNA Repair Inhibitor

David A. Boothman, Sheldon Greer, Arthur B. Pardee

Research output: Contribution to journalArticlepeer-review


3,4-Dihydro-2,2-dimethyl-2H-naptho(l,2,-£]pyran-5,6-dione (β-lapa-chone) is a novel DNA repair inhibitor. It was tested for synergistic X-ray-induced lethality in combination with several halogenated pyrimidine radiosensitizers. Logarithmic-phase growing human epidermoid laryngeal carcinoma (hep-2) cells were allowed to incorporate pyrimidine analogues for 48 h (approximately two cell doublings) and then were X-irradiated and subjected to various posttreatments. β-Lapachone synergistically increased the dose enhancement ratios (DERs) of all analogues screened, with the exception of the 2’-chloro derivative of 5-bromode-oxyuridine. For example, following 5-bromodeoxycytidine sensitization an X-ray DER value of 1.87 ± 0.04 at 1% survival was increased to 3.51 ± 0.42 due to a 4-h post-X-irradiadon exposure to 4 μM β-lapachone. D0and D, values for halogenated pyrimidine-sensitized human epidermoid laryngeal carcinoma cells were decreased 1.4- to 5.4-fold and 1.4- to 4.0-fold, respectively. β-Lapachone had little effect upon the cytotoxicities of unirradiated human epidermoid laryngeal carcinoma cells whether or not they were previously exposed to any of the halogenated pyrimidine radiosensitizers. β-Lapachone treatment following X-irradiation of cells that had not incorporated a pyrimidine analogue exhibited DER values of 138 ± 0.05 and 1.40 ± 0.01 at 10 and 1% survival levels, respectively. β-Lapachone enhanced the radiosensitization of deoxycytidine analogues to a greater extent than the structurally related deoxyuridine analogues. Greater DERs and lower Do and Dq values were found for deoxycytidine than for deoxyuridine analogue radiosensitizers following 0-lapachone treatment. This agent may improve presently used radiation therapies and enhance proposed strategies which utilize deoxycytidine analogue radiosensitization together with protection of normal tissues by tetrahydrouridine to achieve tumor-selective radiotherapy.

Original languageEnglish (US)
Pages (from-to)5401-5406
Number of pages6
JournalCancer Research
Issue number20
StatePublished - 1987

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Potentiation of Halogenated Pyrimidine Radiosensitizers in Human Carcinoma Cells by β-Lapachone (3,4-dihydro-2,2-dimethyl-2h-naphtho[l,2-b]pyran-5,6-dione), a Novel DNA Repair Inhibitor'. Together they form a unique fingerprint.

Cite this